BLCO Bausch + Lomb Corporation
Healthcare$15.78-0.88%ClosedMarket Cap: $5.63B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.89
P/S
1.09
EV/EBITDA
7.52
DCF Value
$9.06
FCF Yield
0.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.9%
Operating Margin
5.9%
Net Margin
-4.2%
ROE
-3.4%
ROA
-1.6%
ROIC
2.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.24B | 56.6% | $59.0M | $-71.0M | $— | — |
| Q4 null | $1.41B | 58.1% | $158.0M | $-58.0M | $— | — |
| FY null | $5.10B | 54.8% | $188.0M | $-360.0M | $— | — |
| Q3 null | $1.28B | 54.9% | $80.0M | $-28.0M | $— | — |
| Q2 null | $1.28B | 53.7% | $11.0M | $-62.0M | $— | — |
| Q1 null | $1.14B | 51.7% | $-61.0M | $-212.0M | $— | — |
| Q4 null | $1.28B | 60.9% | $87.0M | $-3.0M | $— | — |
| FY null | $4.79B | 60.9% | $162.0M | $-317.0M | $— | — |
| Q3 null | $1.20B | 61.2% | $43.0M | $4.0M | $— | — |
| Q2 null | $1.22B | 60.3% | $26.0M | $-151.0M | $— | — |
| Q1 null | $1.10B | 61.4% | $6.0M | $-167.0M | $— | — |
| Q4 2023 | $1.17B | 60.7% | $49.0M | $-54.0M | $-0.15 | — |